- CIIX’s CBD Biotechnology Co. Ltd. explored new partnership opportunities at Vietnam Expo
- CBD Biotech exhibited self-branded, hemp-infused skin care line
- CIIX aims to build new markets for industrial hemp products throughout Asia
ChineseInvestors.com Inc.’s (OTCQB: CIIX) wholly owned foreign enterprise, CBD Biotechnology Co. Ltd., introduced its new efforts in hemp plant extraction and associated cosmetics at the 29th Vietnam Expo in Hanoi, which was held on April 10-13. The company exhibited its self-branded, hemp-infused skin care line, establishing CBD Biotech as one of the first companies in China to offer skin care products infused with hemp oil and hemp leaf extract (http://ibn.fm/wpIGP).
Participating in the event enabled CBD Biotech to explore industrial hemp sales throughout Asia, raise its profile among potential partners and become an influencer in the market. CBD Biotech has been a pioneer in the Chinese market for hemp-infused skin care products and an originator of hemp plant extraction. The company also exhibited its hemp wine at the expo (http://ibn.fm/UvDtK).
“The Vietnam Expo continues to be an important business destination to build bridges for trade promotion, foreign relations, facilitating commerce and attracting trade between Vietnamese and foreign enterprises,” CBD Biotech CEO Summer Yun stated in a news release (http://ibn.fm/5EG6R). “We anticipate creating lucrative export opportunities and exploring possible expansion to more Southeast Asian countries and members of ASEAN.”
CBD Biotech’s current line of skin care products features the Popular Series, Live Oxygen Series, Plant Series and New Products Series.
The Vietnam Expo showcased 760 companies in more than 1,000 booths. Some 35 percent of the booths represent international companies, while 65 percent are companies based in Vietnam.
For more information, visit the company’s website at www.ChineseInvestors.com
NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX
